Genome-wide analysis reveals specificities of Cpf1 endonucleases in human cellsHighly Cited Paper
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Daesik Kim | - |
dc.contributor.author | Jungeun Kim | - |
dc.contributor.author | Junho K Hur | - |
dc.contributor.author | Kyung Wook Been | - |
dc.contributor.author | Sun-Heui Yoon | - |
dc.contributor.author | Jin-Soo Kim | - |
dc.date.available | 2016-10-06T06:35:31Z | - |
dc.date.created | 2016-09-20 | - |
dc.date.issued | 2016-08 | - |
dc.identifier.issn | 1087-0156 | - |
dc.identifier.uri | https://pr.ibs.re.kr/handle/8788114/2800 | - |
dc.description.abstract | Programmable clustered regularly interspaced short palindromic repeats (CRISPR) Cpf1 endonucleases are single-RNA-guided (crRNA) enzymes that recognize thymidine-rich protospacer-adjacent motif (PAM) sequences and produce cohesive double-stranded breaks (DSBs). Genome editing with CRISPR-Cpf1 endonucleases could provide an alternative to CRISPR-Cas9 endonucleases, but the determinants of targeting specificity are not well understood. Using mismatched crRNAs we found that Cpf1 could tolerate single or double mismatches in the 3′ PAM-distal region, but not in the 5′ PAM-proximal region. Genome-wide analysis of cleavage sites in vitro for eight Cpf1 nucleases using Digenome-seq revealed that there were 6 (LbCpf1) and 12 (AsCpf1) cleavage sites per crRNA in the human genome, fewer than are present for Cas9 nucleases (>90). Most Cpf1 off-target cleavage sites did not produce mutations in cells. We found mismatches in either the 3′ PAM-distal region or in the PAM sequence of 12 off-target sites that were validated in vivo. Off-target effects were completely abrogated by using preassembled, recombinant Cpf1 ribonucleoproteins. © 2016 Nature America, Inc. All rights reserved | - |
dc.description.uri | 1 | - |
dc.language | 영어 | - |
dc.publisher | NATURE PUBLISHING GROUP | - |
dc.title | Genome-wide analysis reveals specificities of Cpf1 endonucleases in human cells | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.identifier.wosid | 000381339600024 | - |
dc.identifier.scopusid | 2-s2.0-84981318543 | - |
dc.identifier.rimsid | 56468 | ko |
dc.date.tcdate | 2018-10-01 | - |
dc.contributor.affiliatedAuthor | Daesik Kim | - |
dc.contributor.affiliatedAuthor | Jungeun Kim | - |
dc.contributor.affiliatedAuthor | Junho K Hur | - |
dc.contributor.affiliatedAuthor | Kyung Wook Been | - |
dc.contributor.affiliatedAuthor | Jin-Soo Kim | - |
dc.identifier.doi | 10.1038/nbt.3609 | - |
dc.identifier.bibliographicCitation | NATURE BIOTECHNOLOGY, v.34, no.8, pp.863 - 868 | - |
dc.citation.title | NATURE BIOTECHNOLOGY | - |
dc.citation.volume | 34 | - |
dc.citation.number | 8 | - |
dc.citation.startPage | 863 | - |
dc.citation.endPage | 868 | - |
dc.date.scptcdate | 2018-10-01 | - |
dc.description.wostc | 128 | - |
dc.description.scptc | 133 | - |
dc.embargo.liftdate | 9999-12-31 | - |
dc.embargo.terms | 9999-12-31 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.subject.keywordPlus | RNA-GUIDED ENDONUCLEASES | - |
dc.subject.keywordPlus | OFF-TARGET CLEAVAGE | - |
dc.subject.keywordPlus | CRISPR-CAS SYSTEM | - |
dc.subject.keywordPlus | DIGENOME-SEQ | - |
dc.subject.keywordPlus | NUCLEASES | - |
dc.subject.keywordPlus | RIBONUCLEOPROTEINS | - |
dc.subject.keywordPlus | VECTORS | - |
dc.subject.keywordPlus | TALENS | - |
dc.subject.keywordPlus | SITES | - |